Ujjivan Small Finance Bank has approved a preferential issue of 6.32 crore equity shares at Rs 64.73 each, aiming to raise approximately Rs 409 crore. The capital infusion involves institutional heavyweights, including International Finance Corporation and three major insurance firms. The move is set to strengthen the bank's capital base ahead of the November 13, 2026, Extraordinary General Meeting.
Ujjivan Small Finance Bank Approves Rs 409 Crore Capital Raise
The bank will issue up to 6,31,91,619 equity shares at Rs 64.73 per share.
The total consideration amounts to approximately Rs 409.04 crore to bolster capital adequacy.
Reader Takeaway: Strong institutional backing boosts capital, though shareholder dilution and EGM approval requirements remain key considerations for investors.
What just happened
Ujjivan Small Finance Bank has received board approval for a preferential allotment of equity shares to four qualified institutional buyers. The issue price of Rs 64.73 per share includes a face value of Rs 10 and a premium of Rs 54.73. The proposal is currently pending approval from the bank's shareholders, with an Extraordinary General Meeting (EGM) set for November 13, 2026.
Why this matters
This capital infusion is a strategic move to strengthen the bank's balance sheet and support future growth. By attracting marquee names like the International Finance Corporation (IFC) and major insurers including HDFC Life, Bajaj Life, and Aditya Birla Sun Life, the bank signals institutional confidence. The influx of Rs 409 crore will likely enhance capital adequacy ratios, providing a buffer for lending operations.
Strategic Agreements with IFC
Beyond the capital infusion, Ujjivan SFB has solidified its relationship with IFC. As an existing shareholder, IFC has signed a subscription agreement and a policy agreement. Under the latter, the bank has committed to maintaining specific environmental, social, and governance (ESG) standards, including anti-corruption and reporting protocols, for as long as IFC remains a shareholder.
What to track next
The primary event to monitor is the EGM on November 13, 2026. Shareholders will vote on the resolution, and the company must also secure final regulatory and stock exchange approvals before the shares are allotted.
